Cutaneous manifestations of endemic mycoses

Current Infectious Disease Reports

Volumn 15, Issue 5, 2013, Pages 440-449

  Smith, Jeannina A ^a   Riddell, James ^b   Kauffman, Carol A ^c,d  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

^c UNIVERSITY OF MICHIGAN HEALTH SYSTEM   (United States)

^d VA ANN ARBOR HEALTHCARE SYSTEM   (United States)

Author keywords

Blastomyces dermatitidis; Blastomycosis; Coccidioides species; Coccidioidomycosis; Cutaneous lesions; Histoplasma capsulatum; Histoplasmosis

Indexed keywords

AMPHOTERICIN; ANTIFUNGAL AGENT; ITRACONAZOLE; KETOCONAZOLE; POTASSIUM IODIDE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; BLASTOMYCES DERMATITIDIS; BLASTOMYCOSIS; COCCIDIOIDES IMMITIS; COCCIDIOIDES POSADASII; COCCIDIOIDOMYCOSIS; DIFFERENTIAL DIAGNOSIS; DIMORPHIC FUNGAL INFECTION; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; HISTOPLASMA CAPSULATUM; HISTOPLASMA DUBOISII; HISTOPLASMOSIS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOCOMPROMISED PATIENT; LYMPHADENOPATHY; LYMPHANGITIS; MOUTH LESION; MYCOSIS; NEOPLASM; PATHOGENESIS; POLYMERASE CHAIN REACTION; REVIEW; SHORT COURSE THERAPY; SKIN BIOPSY; SKIN DEFECT; SKIN MANIFESTATION; SKIN NODULE; ULCER;

EID: 84884596953     PISSN: 15233847     EISSN: 15343146     Source Type: Journal    
DOI: 10.1007/s11908-013-0352-2     Document Type: Review

References (80)

1. Kasuga T, White TJ, Koenig G, et al. Phylogeography of the fungal pathogen Histoplasma capsulatum. Mol Ecol. 2003;12:3383-401.
2. Loulegue P, Bastides F, Baudouin V, et al. Literature review and case histories of Histoplasma capsulatum var. duboisii infections in HIV-infected patients. Emerging Infect Dis. 2007;13:1647-52.
3. Antinori S, Magni C, Nebuloni M, et al. Histoplasmosis among human immunodeficiency virus-infected people in Europe. Report of 4 cases and review of the literature. Medicine (Baltimore). 2006;85:22-36.
4. Tosh FE, Balhuizen J, Yates JL, Brasher CA. Primary cutaneous histoplasmosis: report of a case. Arch Intern Med. 1964;114:118-9.
5. Tesh RB, Schneidau JD. Primary cutaneous histoplasmosis. N Engl J Med. 1966;275:597-9.
6. Cott GR, Smith TW, Hinthorn DR, Liu C. Primary cutaneous histoplasmosis in immunosuppressed patient. JAMA. 1979;242:456-7.
7. Sills M, Schwartz A, Weg JG. Conjugal histoplasmosis: a consequence of progressive dissemination in the index case after steroid therapy. Ann Intern Med. 1973;79:221-4.
8. Rosado-Odom VM, Daoud J, Johnson R, et al. Cutaneous presentation of progressive disseminated histoplasmosis nine years after renal transplantation. Transpl Infect Dis. 2013;15:e64-9.
9. McGuinn ML, Lawrence ME, Proia L, Segreti J. Progressive disseminated histoplasmosis presenting as cellulitis in a renal transplant recipient. Transplant Proc. 2005;37:4313-4.
10. Farr B, Beacham BE, Atuk NO. Cutaneous histoplasmosis after renal transplantation. South Med J. 1981;74:635-7.
11. Srivastava B, King B, Galan A. An unusual clinical and histologic presentation of disseminated cutaneous histoplasmosis. J Am Acad Dermatol. 2011;65:e146-8.
12. Scheinfeld N. Diffuse ulcerations due to disseminated histoplasmosis in a patient with HIV. J Drugs Dermatol. 2003;2:189-91.
13. Rosenberg JD, Scheinfeld NS. Cutaneous histoplasmosis in patients with acquired immunodeficiency syndrome. Cutis. 2003;72:439-45.
14. Ramdial KP, Mosam A, Dlova NC, et al. Disseminated cutaneous histoplasmosis in patients infected with human immunodeficiency virus. J Cutan Pathol. 2001;29:215-25.
15. Chang P, Rodas C. Skin lesions in histoplasmosis. Clin Dermatol. 2012;30:592-8.
16. Baddley JW, Sankara IR, Rodriquez JM, et al. Histoplasmosis in HIV-infected patients in a southern regional medical center: poor prognosis in the era of highly active antiretroviral therapy. Diagn Microbiol Infect Dis. 2008;62:151-6.
17. Karimi K, Wheat JL, Connolly P, et al. Differences in histoplasmosis in patients with acquired immunodeficiency syndrome in United States and Brazil. J Infect Dis. 2002;186:1655-60.
18. Gutierrez ME, Canton A, Sosa N, et al. Disseminated histoplasmosis in patients with AIDS in Panama: a review of 104 cases. Clin Infect Dis. 2005;40:1199-202.
19. Thompson GR, La Valle CE, Everett ED. Unusual manifestations of histoplasmosis. Diagn Microbiol Infect Dis. 2004;50:33-41.
20. • Kauffman CA. Histoplasmosis: a clinical and laboratory update. Clin Microbiol Rev. 2007;20:115-32. This is an excellent update on the diagnosis, and management of histoplasmosis.
21. • Cunha VS, Zampese MS, Aquino VR, et al. Mucocutaneous manifestations of disseminated histoplasmosis in patients with acquired immunodeficiency syndrome: particular aspects in a Latin-American population. Clin Exp Dermatol. 2007;32:250-5. This is an excellent update on the diagnosis, and management of blastomycosis.
22. Hernández SL, López de Blanc SA, Sambuelli RH, et al. Oral histoplasmosis associated with HIV infection: a comparative study. J Oral Pathol Med. 2004;33:445-50.
23. Ferreira OG, Cardoso SV, Borges AS, et al. Oral histoplasmosis in Brazil. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2002;93:654-9.
24. Ceccato F, Gongora V, Zunino A, et al. Unusual manifestation of histoplasmosis in connective tissue diseases. Clin Rheumatol. 2007;26:1717-9.
25. Alcure ML, Di Hipólito O, de Almeida OP, et al. Oral histoplasmosis in an HIV-negative patient. Oral Surg Oral Med Oral Pathol Oral Radiol Endodontol. 2006;101:e33-6.
26. Mignogna MD, Fedele S, Lo Russo L, et al. A case of oral localized histoplasmosis in an immunocompetent patient. Eur J Clin Microbiol Infect Dis. 2001;20:753-5.
27. Manfredi R, Mazzoni A, Nanetti A, Chido F. Histoplasma capsulati and duboisii in Europe: the impact of the HIV pandemic, travel, and immigration. Eur J Epidemiol. 1994;10:675-81.
28. Kauffman CA. Histoplasmosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of clinical mycology. 2nd ed. New York: Springer; 2011. p. 321-35.
29. Koepsell SA, Hinrichs SV, Iwen PC. Applying a real-time PCR assay for Histoplasma capsulatum to clinically relevant formalin-fixed paraffin-embedded human tissue. J Clin Microbiol. 2012;50:3395-7.
30. Bialek R, Feucht A, Aepinus C, et al. Evaluation of two nested PCR assays for detection of Histoplasma capsulatum DNA in human tissue. J Clin Microbiol. 2002;40:1644-7.
31. Hage CA, Ribes JA, Wengenack NL, et al. A multicenter evaluation of tests for diagnosis of histoplasmosis. Clin Infect Dis. 2011;53:448-54.
32. Baumgardner DJ, Buggy BP, Mattson BJ, et al. Epidemiology of blastomycosis in a region of high endemicity in north central Wisconsin. Clin Infect Dis. 1992;15:629-35.
33. Gauthier GM, Klein BS. Insights into fungal morphogenesis and immune evasion. Microbe. 2008;3:416-23.
34. Gray NA, Baddour LM. Cutaneous inoculation blastomycosis. Clin Infect Dis. 2002;34:e44-9.
35. Harris JR, Blaney DD, Lindsley MD, et al. Blastomycosis in man after kinkajou bite. Emerg Infect Dis. 2011;17:268-70.
36. Gnann JW, Bressler GS, Bodet II, et al. Human blastomycosis after a dog bite. Ann Intern Med. 1983;98:48-9.
37. Larson DM, Eckman MR, Alber RL, et al. Primary cutaneous (inoculation) blastomycosis: an occupational hazard to pathologists. Am J Clin Pathol. 1983;79:253-5.
38. Gauthier GM, Safdar N, Klein BS, et al. Blastomycosis in solid organ transplant recipients. Transpl Infect Dis. 2007;9:310-7.
39. Pappas PG, Threlkeld MG, Bedsole GD, et al. Blastomycosis in immunocompromised patients. Medicine (Baltimore). 1993;72:311-25.
40. Lemos LB, Baliga M, Guo M. Acute respiratory distress syndrome and blastomycosis: presentation of nine cases and review of the literature. Ann Diagn Pathol. 2001;5:1-9.
41. Saccente M, Woods GL. Clinical and laboratory update on blastomycosis. Clin Microbiol Rev. 2010;23:367-81.
42. Crampton TL, Light RB, Berg GM, et al. Epidemiology and clinical spectrum of blastomycosis diagnosed at Manitoba hospitals. Clin Infect Dis. 2002;34:1310-6.
43. Mason AR, Cortes GY, Cook J, et al. Cutaneous blastomycosis: a diagnostic challenge. Int J Dermatol. 2008;47:824-30.
44. Clinton TS, Timko AL. Cutaneous blastomycosis without evidence of pulmonary involvement. Milit Med. 2003;168:651-3.
45. Bartley GB. Blastomycosis of the eyelid. Ophthalmology. 1995;102:2021-3.
46. Saucier J, Gauthier G. Verrucous lesions and ectropion in an immunocompetent individual. Clin Infect Dis. 2012;55:1426-8.
47. Miller DD, Davies SF, Sarosi GA. Erythema nodosum and blastomycosis. Arch Intern Med. 1982;142:1839.
48. Rose HD, Gingrass DJ. Localized oral blastomycosis mimicking actinomycosis. Oral Surg Oral Med Oral Pathol. 1982;54:12-4.
49. Gerwin KM, Myer CM. Intranasal blastomycosis. Am J Otolaryngol. 1981;2:267-73.
50. Reder PA, Neel HB. Blastomycosis in otolaryngology: review of a large series. Laryngoscope. 1993;103:53-8.
51. Smith JA, Kauffman CA. Blastomycosis. Proc Am Thorac Soc. 2010;7:173-80.
52. Sidamonidze K, Peck MK, Perez M, et al. Real-time PCR assay for identification of Blastomyces dermatitidis in culture and in tissue. J Clin Microbiol. 2013;50:1783-6.
53. Bariola JR, Hage CA, Durkin M, et al. Detection of Blastomyces dermatitidis antigen in patients with newly diagnosed blastomycosis. Diagn Microbiol Infect Dis. 2011;69:187-91.
54. Durkin M, Witt J, Lemonte B, et al. Antigen assay with the potential to aid in the diagnosis of blastomycosis. J Clin Microbiol. 2004;42:4873-5.
55. Chiller TM, Galgiani JN, Stevens DA. Coccidioidomycosis. Infect Dis Clin North Am. 2003;17:41-57.
56. Marsden-Haug N, Goldoft M, Ralston C, et al. Coccidioidomycosis acquired in Washington state. Clin Infect Dis. 2013;56:847-50.
57. Centers for Disease Control and Prevention. Increase in reported coccidioidomycosis - United States, 1998-2011. MMWR. 2013;62:217.
58. Borchers AT, Gershwin ME. The immune response in coccidioidomycosis. Autoimmun Rev. 2010;10:94-102.
59. Blair JE, Logan JL. Coccidioidomycosis in solid organ transplantation. Clin Infect Dis. 2001;33:1536-44.
60. Crum NF, Lederman ER, Stafford CM, et al. Coccidioidomycosis: a descriptive survey of a reemerging disease. Clinical characteristics and current controversies. Medicine (Baltimore). 2004;83:149-75.
61. Wilson JW, Smith CE, Plunkett OA. Primary cutaneous coccidioidomycosis - the criteria for diagnosis and a report of a case. Calif Med. 1953;79:233-9.
62. Chang A, Tung RC, McGillis TS. Primary cutaneous coccidioidomycosis. J Am Acad Dermatol. 2003;49:944-9.
63. Gaidici A, Saubolle MA. Transmission of coccidioidomycosis to a human via a cat. J Clin Microbiol. 2009;47:505-6.
64. Blair JE. State-of-the-art treatment of coccidioidomycosis, skin and soft-tissue infections. Ann N Y Acad Sci. 2007;1111:411-21.
65. Masannat FY, Ampel NM. Coccidioidomycosis in patients with HIV-1 infection in the era of potent antiretroviral therapy. Clin Infect Dis. 2010;50:1-7.
66. Stevens DA. Coccidioidomycosis. N Engl J Med. 1995;332:1077-82.
67. Schwarts RA, Lamberts RJ. Isolated nodular cutaneous coccidioidomycosis. The initial manifestation of disseminated disease. J Am Acad Dermatol. 1981;4:38-46.
68. Carpenter JB, Feldman JS, Leyva WH, DiCaudo DJ. Clinical and pathologic characteristics of disseminated cutaneous coccidioidomycosis. J Am Acad Dermatol. 2010;62:831-7.
69. Quimby SR, Connolly SM, Winkelmann RK, Smilack JD. Clinicopathologic spectrum of specific cutaneous lesions of disseminated coccidioidomycosis. J Am Acad Dermatol. 1992;26:79-85.
70. Rodriguez RA, Konia T. Coccidioidomycosis of the tongue. Arch Pathol Lab Med. 2005;129:e4-6.
71. Polesky AP, Kirsch CM, Snyder LS, et al. Airway coccidioidomycosis: report of cases and review. Clin Infect Dis. 1999;28:1273-80.
72. Boyle JO, Coulthard SW, Mandel RM. Laryngeal involvement in disseminated coccidioidomycosis. Arch Otolaryngol Head Neck Surg. 1991;117:433-8.
73. Echols RM, Palmer DL, Long GW. Tissue eosinophilia in human coccidioidomycosis. Rev Infect Dis. 1982;4:656-64.
74. Ampel NM. Coccidioidomycosis. In: Kauffman CA, Pappas PG, Sobel JD, Dismukes WE, editors. Essentials of clinical mycology. 2nd ed. New York: Springer; 2011. p. 349-66.
75. Mendoza N, Blair JE. The utility of diagnostic testing for active coccidioidomycosis in solid organ transplant recipients. Am J Transpl. 2013;13:1034-9.
76. Pappagianis D. Serologic studies in coccidioidomycosis. Semin Respir Infect. 2001;16:242-50.
77. Kuberski T, Myers R, Wheat LJ, et al. Diagnosis of coccidioidomycosis by antigen detection using cross-reaction with a Histoplasma antigen. Clin Infect Dis. 2007;44:e50-4.
78. •• Wheat LJ, Freifeld AG, Kleiman MB, et al. Clinical practice guideline for the management of patients with histoplasmosis: 2007 update by the Infectious Diseases Society of America. Clin Infect Dis. 2007;45:807-25. These are the updated guidelines from the IDSA and are very helpful in the evaluation and management of patients with suspected Histoplasma.
79. •• Chapman SW, Dismukes WE, Proia LA, et al. Clinical practice guidelines for the management of blastomycosis: 2008 update by the Infectious Diseases Society of America. Clin Infect Dis. 2008;46:1801-12. These are the updated guidelines from the IDSA and are very helpful in the evaluation and management of patients with suspected blastomycosis.
80. •• Galgiani JN, Ampel NM, Blair JE, et al. Coccidioidomycosis. Clin Infect Dis. 2005;41:1217-23. These are the current guidelines from the IDSA for the evaluation and management of patients with suspected coccidioidomycosis. Updated guidelines expected shortly.